Patent details
301031
Product Name:
Plerixafor, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of metaalcomplex daarvan
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301031
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2371361
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
301031
Procedural language:
Dutch
First Applicant Residence Country:
Netherlands (NL)
Marketing Authorization
Marketing Authorization Number:
EU/1/09/537/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
04/08/2009
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
22/01/2020
First Marketing Authorization date:
04/08/2009
Grant date:
20/07/2020
Activation date:
30/07/2022
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
31/01/2020
SPC/SPC Extension Expiration Date:
03/08/2024
Lapsed By Expiration Date:
04/08/2024
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
22/05/2023
Name:
Sanofi B.V.
Address:
Paasheuvelweg 25, 1105 BP, Amsterdam, Netherlands (NL)
Historical Applicant/holder
From:
22/01/2020
To:
22/05/2023
Name:
GENZYME EUROPE B.V.
Address:
Paasheuvelweg 25, 1105 BP, Amsterdam, Netherlands (NL)
Agent
Name:
ir. H.A. Witmans c.s.
From:
22/01/2020
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
32/24
Publication date:
07/08/2024
Description:
Lapse or annulment
2
Bulletin Heading:
CO
Journal edition number:
23/23
Publication date:
07/06/2023
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
SPC
Journal edition number:
31/22
Publication date:
03/08/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
30/20
Publication date:
22/07/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
Bulletin Heading:
SPC
Journal edition number:
06/20
Publication date:
05/02/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202301018A
Date Registered:
22/05/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Sanofi B.V.
Address:
Paasheuvelweg 25, 1105 BP, Amsterdam, Netherlands (NL)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
16/07/2024
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Arnold & Siedsma BV
Filing date
Document type
Document Description
Number of pages
File Type
21/07/2020
Front Page
Front Page
1
PDF
/7/6/7/1/1/0800511767/docs/301031_9_i2frontpage20200721101534554.pdf
20/07/2020
SPC Documents
Certificate SPC
1
PDF
/7/6/7/1/1/0800511767/docs/301031_12_supplprotectioncertificate20200721095142703.pdf
20/07/2020
Outgoing Correspondence
Decision grant
3
PDF
/7/6/7/1/1/0800511767/docs/301031_15_355202l504a.pdf
16/07/2020
Outgoing Correspondence
Confirmation receipt communication third party
1
PDF
/7/6/7/1/1/0800511767/docs/301031_0_354781l037.pdf
16/07/2020
Outgoing Correspondence
Letter communication third party to holder
1
PDF
/7/6/7/1/1/0800511767/docs/301031_14_354763l035.pdf
15/07/2020
SPC Documents
Annex third party observations SPC
5
PDF
/7/6/7/1/1/0800511767/docs/301031_3_supplprotectioncertificate20200716105403705.pdf
15/07/2020
SPC Documents
Third party observations SPC
6
PDF
/7/6/7/1/1/0800511767/docs/301031_4_supplprotectioncertificate20200716105630900.pdf
15/07/2020
SPC Documents
Annex third party observations SPC
294
PDF
/7/6/7/1/1/0800511767/docs/301031_17_supplprotectioncertificate20200716110243834.pdf
03/02/2020
Front Page
Front Page
1
PDF
/7/6/7/1/1/0800511767/docs/301031_2_i1frontpage20200203104459172.pdf
03/02/2020
Outgoing Correspondence
Confirmation receipt request
1
PDF
/7/6/7/1/1/0800511767/docs/301031_16_323513l174.pdf
22/01/2020
SPC Documents
Annex SPC
1
PDF
/7/6/7/1/1/0800511767/docs/301031_1_supplprotectioncertificate20200131125444035.pdf
22/01/2020
SPC Documents
Summary of the characteristics of the product
12
PDF
/7/6/7/1/1/0800511767/docs/301031_5_supplprotectioncertificate20200131125443685.pdf
22/01/2020
SPC Documents
Annex SPC
11
PDF
/7/6/7/1/1/0800511767/docs/301031_6_supplprotectioncertificate20200131125443856.pdf
22/01/2020
Application Form
First filed application form
3
PDF
/7/6/7/1/1/0800511767/docs/301031_7_applicationform20200131125443288.pdf
22/01/2020
SPC Documents
Marketing Authorization SPC
3
PDF
/7/6/7/1/1/0800511767/docs/301031_8_supplprotectioncertificate20200131125443604.pdf
22/01/2020
SPC Documents
Annex SPC
1
PDF
/7/6/7/1/1/0800511767/docs/301031_10_supplprotectioncertificate20200131125443958.pdf
22/01/2020
SPC Documents
Annex SPC
2
PDF
/7/6/7/1/1/0800511767/docs/301031_11_supplprotectioncertificate20200131125443761.pdf
22/01/2020
SPC Documents
Annex SPC
3
PDF
/7/6/7/1/1/0800511767/docs/301031_13_supplprotectioncertificate20200131125443508.pdf